文献速递关节外科

全膝关节置换术后感染取出假体并置入间隔物后重复清创、间隔物保留、截肢、关节融合及死亡的风险因素

Risk Factors for Repeat Debridement, Spacer Retention, Amputation, Arthrodesis, and Mortality After Removal of an Infected Total Knee Arthroplasty With Spacer Placement.
PubMed 文献 · J Arthroplasty · 2017-09-05

基于Medicare数据库纳入18533例因慢性假体周围感染取出全膝关节置换假体并置入抗生素间隔物的患者,术后1年内691例(3.7%)院内死亡、852例(4.5%)行膝关节融合、574例(3.1%)截肢、2683例(14.5%)行重复清创未再置入、2323例(12.5%)保留间隔物、11420例(61.6%)取出间隔物并再置入。多因素logistic回归识别了多种独立风险因素,38.4%的患者1年内未再置入。

要点

  • 18533例患者中1年内再置入率为61.6%,38.4%未再置入。
  • 1年内院内死亡3.7%、关节融合4.5%、截肢3.1%。
  • 重复清创未再置入占14.5%,保留间隔物占12.5%。

核心结论

  • 大量患者(38.4%)在取出假体并置入间隔物后1年内未行再置入。
  • 取出假体并置入抗生素间隔物后的结局多样,存在若干独立风险因素,可用于制定和改进慢性假体周围感染的治疗策略。

研究设计与样本

  • 在Medicare数据库中识别因假体周围感染行感染全膝关节置换假体取出并置入抗生素间隔物的患者。
  • 识别术后1年内出现研究结局的患者,并用多因素logistic回归分析这些结局的独立风险因素。

主要发现

  • 共纳入18533例患者。
  • 术后1年内,691例(3.7%)在医院内死亡,852例(4.5%)行膝关节融合,574例(3.1%)行截肢,2683例(14.5%)行重复清创但未再置入,2323例(12.5%)保留间隔物,11420例(61.6%)取出间隔物并再置入。
  • 识别出多种与患者相关的独立风险因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic periprosthetic joint infection (PJI) after total knee arthroplasty (TKA) is most commonly addressed with a 2-stage exchange procedure. The purpose of this study is to examine the natural history of patients who have undergone prosthesis removal and spacer placement and evaluate risk factors for outcomes other than reimplantation. METHODS: Patients who underwent removal of an infected TKA and placement of an antibiotic spacer for PJI were identified in a Medicare database. Patients with a study outcome within 1 year were then identified: (1) in hospital mortality, (2) knee arthrodesis, (3) amputation, (4) repeat debridement procedure without reimplantation, and (5) reimplantation. Independent risk factors for these outcomes were evaluated with a multivariate logistic regression analysis. RESULTS: A total of 18,533 patients were included. Within 1 year postoperatively, 691 patients (3.7%) died in a hospital setting, 852 patients (4.5%) underwent a knee arthrodesis, 574 patients (3.1%) underwent an amputation, 2683 patients (14.5%) underwent a repeat debridement procedure without being reimplanted, 2323 patients (12.5%) retained their spacer, and 11,420 patients (61.6%) underwent spacer removal and reimplantation within 1 year. Numerous independent patient-related risk factors for these outcomes were identified. CONCLUSION: A large number of patients (38.4%) do not undergo reimplantation within 1 year of prosthesis removal and spacer placement. Outcomes after prosthesis removal and antibiotic spacer placement are variable, and there are several independent risk factors for such outcomes that may be used to develop and improve existing treatment strategies for patients presenting with chronic PJI after TKA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Cancienne JM, Granadillo VA, Patel KJ, et al. Risk Factors for Repeat Debridement, Spacer Retention, Amputation, Arthrodesis, and Mortality After Removal of an Infected Total Knee Arthroplasty With Spacer Placement. J Arthroplasty. 2017. PMID: 28958659. doi:10.1016/j.arth.2017.08.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。